Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study of SARS-CoV-2 Donor-Recipient Immunity Transfer

NCT04666025 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT04666025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04666025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study of SARS-CoV-2 Donor-Recipient Immunity Transfer
Lead sponsor
City of Hope Medical Center
Phase
Observational
Overall status
Completed
Start date
September 23, 2020
Completion date
May 5, 2023
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

accelerated phase cml, bcr-abl1 positive, acute lymphoblastic leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, chronic phase cml, bcr-abl1 positive, covid-19 infection, hematopoietic and lymphoid cell neoplasm, hodgkin lymphoma, lymphoblastic lymphoma, myelodysplastic syndrome, myelofibrosis, myeloproliferative neoplasm, non-hodgkin lymphoma